Page 4 - Integral Diagnostics News Today

Key Insights The projected fair value for Integral Diagnostics is AU$3.64 based on 2 Stage Free Cash Flow to Equity...

Integral Diagnostics Limited (OTCMKTS:ITGDF – Get Rating) was the target of a large increase in short interest during the month of May. As of May 15th, there was short interest totalling 672,400 shares, an increase of 65.8% from the April 30th total of 405,600 shares. Based on an average daily volume of 0 shares, the […]

The company was to be sold to ASX-listed Integral Diagnostics until the deal fell over in October.

With the population over 65 expected to grow at twice the rate of the Australian population, likely winners include healthcare companies and financial services.

Integral Diagnostics (OTCMKTS:ITGDF – Get Rating) was downgraded by equities research analysts at Royal Bank of Canada to a “sector perform” rating in a research note issued to investors on Monday, The Fly reports. Integral Diagnostics Stock Performance OTCMKTS ITGDF opened at $2.00 on Monday. Integral Diagnostics has a 1 year low of $2.00 and […]

Weekly Broker Wrap: Jarden's preferred exposures to online retail, online penetration trends & the improving outlook for diagnostic imaging in Australia

Cincinnati, OH (PRWEB) January 12, 2023 -- Today, Integral Diagnostics (IDX), a leading provider of medical imaging services across Australia and New Zealand,

Welcome to the December 2022 Investment Update for the Switzer Dividend Growth Fund . Click here to download the report. Performance Summary ... | January 9, 2023

IFM Investors has teamed up with industry superannuation fund UniSuper to buy a majority stake in radiology business PRP Diagnostic.

Australian shares advanced 2.1 per cent at the open led by energy, tech, consumer stocks. Australian dollar is at US63.7¢. RBA’s Kent $A fall only modestly inflationary. Global PMIs ahead, federal budget tomorrow. Follow here.